Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,014
  • Shares Outstanding, K 3,468
  • Annual Sales, $ 1,310 K
  • Annual Income, $ -8,310 K
  • EBIT $ -4 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.98
  • Price/Sales 1.56
  • Price/Cash Flow N/A
  • Price/Book 0.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -9.57
  • Most Recent Earnings $-10.40 on 05/07/25
  • Next Earnings Date 07/01/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5500 +5.58%
on 03/26/26
0.7768 -25.24%
on 03/11/26
-0.1677 (-22.41%)
since 03/10/26
3-Month
0.5500 +5.58%
on 03/26/26
1.1200 -48.15%
on 01/27/26
-0.1813 (-23.79%)
since 01/09/26
52-Week
0.5500 +5.58%
on 03/26/26
6.1800 -90.60%
on 06/05/25
-1.6193 (-73.60%)
since 04/10/25

Most Recent Stories

More News
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities

JERUSALEM , April 6, 2026 /PRNewswire/ --  Scinai Immunotherapeutics Ltd.  (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company developing inflammation and immunology...

SCNI : 0.5807 (-1.64%)
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration

JERUSALEM , April 1, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company operating a dual R&D and CDMO business...

SCNI : 0.5807 (-1.64%)
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026

JERUSALEM , March 19, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics,...

SCNI : 0.5807 (-1.64%)
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

JERUSALEM , March 16, 2026 /PRNewswire/ --  Scinai Immunotherapeutics Ltd.  (Nasdaq: SCNI) ("Scinai" or the "Company"), today announced that it received a written notification from...

SCNI : 0.5807 (-1.64%)
Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

JERUSALEM , March 2, 2026 /PRNewswire/ --  Scinai Immunotherapeutics Ltd.  (Nasdaq: SCNI);("Scinai" or the "Company"), today announced the execution of a Second Amendment to its Binding...

SCNI : 0.5807 (-1.64%)
Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform

JERUSALEM , Feb. 25, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI);("Scinai", or the "Company"), today announced that, following an additional review by the Israel...

SCNI : 0.5807 (-1.64%)
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm

JERUSALEM , Feb. 17, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd .  (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company developing inflammation and immunology...

SCNI : 0.5807 (-1.64%)
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL

JERUSALEM , Jan. 7, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI); ("Scinai", or the "Company"), a biopharmaceutical company developing inflammation and immunology (I&I)...

SCNI : 0.5807 (-1.64%)
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances

JERUSALEM , Dec. 2, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company developing innovative inflammation and immunology...

SCNI : 0.5807 (-1.64%)
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Scinai Immunotherapeutics...

SCNI : 0.5807 (-1.64%)

Business Summary

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 0.6518
2nd Resistance Point 0.6325
1st Resistance Point 0.6066
Last Price 0.5807
1st Support Level 0.5614
2nd Support Level 0.5421
3rd Support Level 0.5162

See More

52-Week High 6.1800
Fibonacci 61.8% 4.0293
Fibonacci 50% 3.3650
Fibonacci 38.2% 2.7007
Last Price 0.5807
52-Week Low 0.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.